Second-Line Oxaliplatin, Folinic Acid, and Fluorouracil Versus Folinic Acid and Fluorouracil Alone for Gemcitabine-Refractory Pancreatic Cancer: Outcomes From the CONKO-003 Trial von OETTLE, Helmut, RIESS, Hanno, BISCHOFF, Sven, SINN, Marianne, DÖRKEN, Bernd, PELZER, Uwe, STIELER, Jens M, HEIL, Gerhard, SCHWANER, Ingo, SERAPHIN, Jörg, GÖRNER, Martin, MÖLLE, Matthias, GRETEN, Tim F, LAKNER, Volker

Volltext

Phase II Study of Capecitabine Plus Trastuzumab in Human Epidermal Growth Factor Receptor 2–Overexpressing Metastatic Breast Cancer Pretreated With Anthracyclines or Taxanes von SCHALLER, Gerhard, FUCHS, Ilka, GONSCH, Thomas, WEBER, Jan, KLEINE-TEBBE, Anke, KLARE, Peter, HINDENBURG, Hans-Joachim, LAKNER, Volker, HINKE, Axel, BANGEMANN, Nikola

Volltext

Long-term follow-up of rituximab plus first-line mitoxantrone, chlorambucil, prednisolone and interferon-alpha as maintenance therapy in follicular lymphoma von Herold, Michael, Scholz, Christian W., Rothmann, Frank, Hirt, Carsten, Lakner, Volker, Naumann, Ralph

Volltext

Fludarabine and Bendamustine in Refractory and Relapsed Indolent Lymphoma-a Multicenter Phase I/II Trial of the East German Society of Hematology and Oncology (OSHO) von Koenigsmann, Michael, Knauf, Wolfgang U, Herold, Michael, Pasold, Rita, Müller, Gerd, Eschenburg, Henning, Kahl, Christoph, Lakner, Volker, Aßmann, Michael, Jentsch-Ullrich, Kathleen, Mohren, Martin, Bartsch, Rainer, Franke, Astrid

Volltext

Imatinib (IM) in Combination with Hydroxyurea Showed Significantly Lower Major Molecular Response Rates at 6 Months but Similar MMR at 18 Months in Patients with CML1st CP Compared... von Lange, Thoralf, Krahl, Rainer, von Grünhagen, Ulrich, Al-Ali, Haifa Kathrin, Andreas, Schwarzer, Jentsch-Ulrich, Kathleen, Spohn, Claudia, Lakner, Volker, Assmann, Michael, Junghanss, Christian, Pfirrmann, Markus, Gil, Arthur, Hehlmann, Rüdiger, Deininger, Michael W., Niederwieser, Dietger

Volltext

Results of a Prospective Randomised Open Label Phase III Study Comparing Rituximab Plus Mitoxantrone, Chlorambucile, Prednisolone Chemotherapy (R-MCP) Versus MCP Alone in Untreated... von Herold, Michael, Pasold, Rita, Srock, Stefanie, Neser, Sabine, Niederwieser, Dietger, Neubauer, Andreas, Dölken, Gottfried, Naumann, Ralph, Fietz, Thomas, Freund, Mathias, Rohrberg, Robert, Hoeffken, Klaus, Franke, Astrid, Ittel, Thomas H., Kettner, Erika, Haak, Ursula, Mey, Ullrich, Klinkenstein, Christian, Assmann, Michael, von Gruenhagen, Ullrich, Dachselt, Klaus, Schwenke, Helga, Bleyl, Dorothee, Wolf, Heiner, Hahnfeld, Sabine, Hoffmann, Franz-Adolph, Lakner, Volker, Richter, Peter, Hähling, Detlev, Wolf, H.H., Eschenburg, Henning, Clemens, M.-R., Grobe, Norbert

Volltext

Cost Evaluation of Rituximab Plus MCP vs. MCP Alone in Advanced Stage Indolent Non-Hodgkin's-Lymphoma Based on a Randomized Controlled Multicenter Trial von Hieke, Klaus, Pasold, Rita, Neser, Sabine, Niederwieser, Dietger, Neubauer, Andreas, Doelken, Gottfried, Naumann, Ralph, Fietz, Thomas, Freund, Mathias, Rohrberg, Robert, Hoeffken, Klaus, Franke, Astrid, Ittel, Thomas-Hein, Kettner, Erika, Haak, Ursula, Mey, Ullrich, Klinkenstein, Christian, Assmann, M., von Gruenhagen, Ullrich, Dachselt, Klaus, Schwenke, Helga, Bleyl, Dorothee, Wolf, Heiner, Hahnfels, Sabine, Hoffmann, Franz-Adolph, Lakner, Volker, Richter, Peter, Haehling, Detlev, Wolf, H.H., Eschenburg, H., Grobe, N., Clemens, M.-R., Herold, Michael

Volltext

A linear megaplasmid, p1CP, carrying the genes for chlorocatechol catabolism of Rhodococcus opacus 1CP von Konig, Christina, Eulberg, Dirk, Groning, Janosch, Lakner, Silvia, Seibert, Volker, Kaschabek, Stefan R, Schlomann, Michael

Volltext